X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28) 28
humans (26) 26
male (25) 25
female (24) 24
middle aged (19) 19
experiment (16) 16
adult (15) 15
aged (15) 15
high energy physics - experiment (14) 14
physics (14) 14
particle physics (13) 13
mortality (12) 12
surgery (11) 11
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (10) 10
high energy physics (10) 10
physics - high energy physics - experiment (10) 10
abridged index medicus (8) 8
analysis (8) 8
risk factors (8) 8
adolescent (7) 7
health aspects (7) 7
physics of elementary particles and fields (7) 7
heart attacks (6) 6
large hadron collider (6) 6
phenomenology (6) 6
research (6) 6
astrophysics (5) 5
cardiac & cardiovascular systems (5) 5
cardiovascular disease (5) 5
care and treatment (5) 5
cern lhc coll (5) 5
child (5) 5
diagnosis (5) 5
medical research (5) 5
patients (5) 5
stroke (5) 5
therapy (5) 5
young adult (5) 5
114 physical sciences (4) 4
adults (4) 4
aged, 80 and over (4) 4
animals (4) 4
article (4) 4
child, preschool (4) 4
children (4) 4
clinical neurology (4) 4
clinical trials (4) 4
cross-sectional studies (4) 4
drug therapy (4) 4
elementary particles, quantum field theory (4) 4
experimental results (4) 4
health risk assessment (4) 4
infarction (4) 4
infections (4) 4
internal medicine (4) 4
ischemia (4) 4
management (4) 4
myocardial infarction (4) 4
nuclear experiment (4) 4
orthopedics (4) 4
particle physics - experiment (4) 4
patient outcomes (4) 4
performance of high energy physics detectors (4) 4
physics, particles & fields (4) 4
prevalence studies (4) 4
public health (4) 4
quantum field theories, string theory (4) 4
registries (4) 4
risk (4) 4
studies (4) 4
13000 gev-cms (3) 3
acute coronary syndromes (3) 3
allergy and immunology (3) 3
association (3) 3
asthma (3) 3
broken symmetries (3) 3
cardiovascular (3) 3
cardiovascular agents (3) 3
case-control studies (3) 3
cerebral infarction (3) 3
confidence intervals (3) 3
coronary heart disease (3) 3
demographic aspects (3) 3
diabetes (3) 3
disease (3) 3
double-blind method (3) 3
electronic books (3) 3
física (3) 3
gastroenterology and hepatology (3) 3
genetic aspects (3) 3
hadron-hadron scattering (3) 3
heart (3) 3
hep (3) 3
high energy astrophysical phenomena (3) 3
hispanics (3) 3
impact (3) 3
infant (3) 3
infant, newborn (3) 3
infectious diseases (3) 3
large detector-systems performance (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Assimes, Themistocles L., MD, PhD and Hólm, Hilma, MD and Kathiresan, Sekar, MD and Reilly, Muredach P., MB and Thorleifsson, Gudmar, PhD and Voight, Benjamin F., PhD and Erdmann, Jeanette, PhD and Willenborg, Christina, MSc and Vaidya, Dhananjay, MBBS, PhD, MPH and Xie, Changchun, PhD and Patterson, Chris C., PhD and Morgan, Thomas M., MD and Burnett, Mary Susan, PhD and Li, Mingyao, PhD and Hlatky, Mark A., MD and Knowles, Joshua W., MD, PhD and Thompson, John R., PhD and Absher, Devin, PhD and Iribarren, Carlos, MD, MPH, PhD and Go, Alan, MD and Fortmann, Stephen P., MD and Sidney, Stephen, MD, MPH and Risch, Neil, PhD and Tang, Hua, PhD and Myers, Richard M., PhD and Berger, Klaus, MD and Stoll, Monika, PhD and Shah, Svati H., MD, MHS and Thorgeirsson, Gudmundur, MD, PhD and Andersen, Karl, MD, PhD and Havulinna, Aki S., MSc and Herrera, J. Enrique, MS and Faraday, Nauder, MD and Kim, Yoonhee, PhD and Kral, Brian G., MD, MPH and Mathias, Rasika A., ScD and Ruczinski, Ingo, PhD and Suktitipat, Bhoom, MD and Wilson, Alexander F., PhD and Yanek, Lisa R., MPH and Becker, Lewis C., MD and Linsel-Nitschke, Patrick, MD and Lieb, Wolfgang, MD and König, Inke R., PhD and Hengstenberg, Christian, MD and Fischer, Marcus, MD and Stark, Klaus, PhD and Reinhard, Wibke, MD and Winogradow, Janina, MD and Grassl, Martina, MD and Grosshennig, Anika, MSc and Preuss, Michael, MSc and Schreiber, Stefan, MD and Wichmann, H.-Erich, MD and Meisinger, Christa, MD, MPH and Yee, Jean, BS and Friedlander, Yechiel, PhD and Do, Ron, MSc and Meigs, James B., MD, MPH and Williams, Gordon, MD and Nathan, David M., MD and MacRae, Calum A., MD, PhD and Qu, Liming, MS and Wilensky, Robert L., MD and Matthai, William H., MD and Qasim, Atif N., MD and Hakonarson, Hakon, MD, PhD and Pichard, Augusto D., MD and Kent, Kenneth M., MD, PhD and Satler, Lowell, MD and Lindsay, Joseph M., MD and Waksman, Ron, MD and Knouff, Christopher W., MD, PhD and Waterworth, Dawn M., PhD and Walker, Max C., BSc and Mooser, Vincent E., MD and Marrugat, Jaume, MD, PhD and Lucas, Gavin, PhD and Subirana, Isaac, MSc and Sala, Joan, MD and Ramos, Rafael, MD, PhD and Martinelli, Nicola, MD and Olivieri, Oliviero, MD and Trabetti, Elisabetta, PhD and Malerba, Giovanni, PhD and Pignatti, Pier Franco, MD and Guiducci, Candace, BS and Mirel, Daniel, PhD and Parkin, Melissa, BS and Hirschhorn, Joel N., MD, PhD and Asselta, Rosanna, PhD and Duga, Stefano, PhD and Musunuru, Kiran, MD, PhD, MPH and Daly, Mark J., PhD and Purcell, Shaun, PhD and Eifert, Sandra, MD and Braund, Peter S., MSc and Wright, Benjamin J., PhD and Balmforth, Anthony J., PhD and Ball, Stephen G., PhD and ... and Cardiogenics and Wellcome Trust Case Control and Myocardial Infarction Genet and Wellcome Trust Case Control Consortium and Myocardial Infarction Genetics Consortium and Kardiovaskulär forskning - hypertoni and Cardiovascular Research - Hypertension and EpiHealth: Epidemiology for Health and Lund University and Lunds universitet and EXODIAB: Excellence in Diabetes Research in Sweden
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 19, pp. 1552 - 1563
Objectives We sought to replicate the association between the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism (rs20455), and clinical coronary artery... 
Cardiovascular | Internal Medicine | coronary artery disease | polymorphism | KIF6 | kinesin-like protein 6 | myocardial infarction | OR | single nucleotide polymorphism | CI | CAD | Abbreviations and Acronyms | HR | odds ratio | SNP | hazard ratio | confidence interval | MI | POPULATION | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | GENOMEWIDE ASSOCIATION | GENOTYPE DATA | HEART-DISEASE | GENE VARIANTS | CHROMOSOME 9P21.3 | CARDIOVASCULAR-DISEASE | NONFATAL MYOCARDIAL-INFARCTION | HEALTH | Humans | Middle Aged | Risk Factors | Tryptophan - genetics | Male | Coronary Artery Disease - enzymology | Case-Control Studies | Internationality | Arginine - genetics | Coronary Artery Disease - genetics | Kinesin - genetics | Polymorphism, Single Nucleotide - genetics | Female | Coronary Artery Disease - epidemiology | Genome-Wide Association Study - methods | Hypertension | Medical colleges | Medical research | Genetic disorders | Environmental health | Chronic diseases | Family medicine | Coronary heart disease | Population genetics | Biometry | Anopheles | Medicine, Experimental | Genetic aspects | Diabetes | Cardiology | Public health | Medical informatics | Kinesin | Heart | Heart attacks | African Americans | Cardiovascular disease | Genomes | Proteins | Studies | Confidence intervals | Consortia | International organizations | Ischemia | Womens health | Atherosclerosis | Age | Hispanics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | myocardial | Medicin och hälsovetenskap | infarction | Klinisk medicin
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 2, pp. AB188 - AB188
Journal Article
American Heart Journal, ISSN 0002-8703, 04/2018, Volume 198, pp. 129 - 134
Previous evidence suggests that acute treatment with statins reduce atherosclerotic complications, including periprocedural myocardial infarction, but... 
IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | METAANALYSIS | EFFICACY | PERCUTANEOUS INTERVENTION | ELEVATION | RANDOMIZED-TRIAL | PERIPROCEDURAL MYOCARDIAL-INFARCTION | EVENT REDUCTION | ATORVASTATIN | Prognosis | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Myocardial Revascularization - methods | Male | Dose-Response Relationship, Drug | Percutaneous Coronary Intervention - methods | Brazil | Female | Double-Blind Method | Drug Administration Schedule | Myocardial Revascularization - mortality | Risk Assessment | Acute Coronary Syndrome - diagnostic imaging | Atorvastatin - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Postoperative Care - methods | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Acute Coronary Syndrome - surgery | Aged | Preoperative Care - methods | Transluminal angioplasty | Medical research | Coronary artery bypass | Cardiac patients | Mortality | Medicine, Experimental | Health aspects | Coronary heart disease | Statins | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Evaluation | Stroke | Heart attacks | Complications | Clinical trials | Cardiovascular disease | Angina pectoris | Patients | Meta-analysis | Studies | Randomization | Arteriosclerosis | Atherosclerosis | Biomarkers | Atorvastatin | Infarction | Acute coronary syndromes | Health risk assessment
Journal Article
American Heart Journal, ISSN 0002-8703, 02/2017, Volume 184, pp. 88 - 96
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 12, pp. 1356 - 1363
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9972, pp. 977 - 1010
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Summary Background Problems associated with lifelong antiretroviral therapy, such as need for strict adherence, drug-related toxic effects, difficulties with... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | EFFICACY | SAFETY | NAIVE HIV-1-INFECTED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | INFECTED PATIENTS | PROTEASE INHIBITORS | TENOFOVIR | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article